Frequently Asked Questions
Suboxone is an FDA approved opioid addiction treatment.
Opiates, also known as “Opioid Painkillers,” include prescription drugs such as Hydrocodone, Fentanyl and Morphine. These substances are effective pain relievers when taken as directed by a physician. Signs of addiction include taking the medication more frequently or in larger amounts than originally prescribed.
Continued opiate misuse can lead to dangerous dose escalation and even conversion to the intravenous opiate, heroin. Getting addiction under control can be very difficult without the help of medical professionals. If you or a loved one is struggling with a dependence on painkillers, it’s important to take action immediately before the situation becomes worse.
The number of treatments varies by client and is determined by the Physician. clients with a history IV heroin use, prior relapse off of treatment, limited social support or lack of employment can expect to remain in treatment longer than clients who have never used heroin and have strong social support systems. On average, at least 12 months of treatment is necessary for even those with a lower risk for relapse.
The frequency of the doctor visits is at least once monthly. The frequency of the medication varies by brand. Some oral medications are once daily, others twice. There are also once monthly dosing options.
No. Payments forms accepted include cash, credit card and check. You may use your insurance to cover the cost of your prescriptions. Prior authorizations services are included in the monthly fee. Processing of claims by your insurance provider would negate the privacy model provided by Karta Health. Underwriters are provided all information gathered by your insurance company. For this reason, many Karta Health clients do not even use their insurance to cover the cost of their medications.
Appointments are available as early as same day, based on client need and physician availability.
Traditional Methadone and Suboxone clinics are not able to do much to protect your privacy. Everyone in the waiting room knows exactly why you are there. The Karta Health model is unique in that we integrate our patients into traditional Neurology practices. There is no public stigma attached to seeing a Karta physician for Opiate treatment
Buprenorphine works in the brain as a partial opiate agonist. It replaces the opiate the user has been abusing, filling opiate receptors in the brain and keeping them from experiencing withdrawal symptoms. Naloxone is included in the formulation to keep people from injecting and abusing the medication. It is an opiate antagonist that blocks the effects of opioids such as morphine, codeine, and heroin. Naloxone stays inactive if used sublingually (under the tongue). However, if it is crushed and injected, while attempting to abuse the medication, the naloxone becomes active in the brain and causes, in an opiate-dependent person, immediate feelings of withdrawal.
Methadone is a full opioid agonist. Methadone binds the opiate receptor where methadone mimics the endorphins, keeping the user from experiencing withdrawal symptoms. Methadone dosing in an outpatient treatment program is closely monitored with witnessed daily dosing. A majority of patients in outpatient treatment programs require 80–125 mg/d of methadone or more and require treatment for an indefinite period of time, since methadone maintenance is a corrective but not a curative treatment for opiate addiction.
Treatment with any Karta network physician is an entirely different experience than a ‘cattle call’ at a Suboxone clinic. Karta Health provides a one-to-one, physician-to-client treatment session, in a private practice setting. This treatment setting affords professionals and those requiring complete anonymity an opportunity to receive the privacy they need and the treatment they deserve.
Suboxone is used to treat pain in some states, but Karta physicians only prescribe Suboxone and other forms of buprenorphine for opiate addiction. Please consult a local pain management practice for further guidance regarding pain management. Currently, it is not legal to prescribe Suboxone to treat pain in the state of Tennessee.
Public exposure for private treatment is always risky for licensed professionals. Our unique treatment model helps mitigate that risk. Your privacy is our utmost priority. Your information is always protected and never reported to insurance companies or licensure boards. Getting help should be nobody’s business but yours.
Our treatment model is designed to protect you from the prying eyes of insurance companies and licensure boards. We operate on a simple cash payment system. We do not involve your insurance company–to best insure your maximum privacy. Any medical information that we collect from you during treatment by a Southern Practice physician is also further protected under specific Federal regulations governing Confidentiality of Alcohol and Drug Abuse Patient Records, 42 C.F.R. Part 2, and the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), 45 C.F.R. Pts. 160 & 164 and cannot be disclosed without written consent. The Federal rules restrict any use of this information to criminally investigate or prosecute any alcohol or drug abuse patient.
Suboxone, Zubsolv, and Bunavail contain both Buprenorphine and the opiate antagonist Naloxone. Naloxone has been added to guard against abuse of Buprenorphine by individuals physically dependent on other Opiates. Buprenorphine is different from other Opioids in that it is a Partial Opioid Agonist (it doesn’t fit the receptors on the brain as well, so it doesn’t stimulate them as much). This property of Buprenorphine may allow for the following: 1. Less euphoria and physical dependence 2. Lower potential for misuse 3. A ceiling on the effects of opioids and 4. A relatively mild withdrawal profile
Total abstinence from all opiates is the ideal outcome, but is not realistic for every person. For many, maintenance of a buprenorphine product is the most responsible way to significantly reduce the odds of a potentially deadly relapse.
Send us an email